| Group 1 (Amniotomy) | Group 2 (Oxytocin) | Group 3 (Amniotomy and Oxytocin) | Group 4 (Control) |  |
---|---|---|---|---|---|
Obstetric and demographic data | N = 49 | N = 52 | N = 55 | N = 47 | p |
Intra-partum fever | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | --- |
Antibiotics use | 1 (2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.5 |
Epidural use | 6 (12) | 15 (29) | 11 (20) | 10 (21) | 0.2 |
Fetal scalp pH | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ----- |
Vaginal examinations | 5.0 ± 1.7 (5) | 6.0 ± 2.6 (5) | 4.8 ± 1.7 (5) | 5.0 ± 1.7 (5.0) | 0.1 |
Fetal Scalp electrode | 3 (6) | 1 (2) | 8 (15)d | 8 (17)d | 0.03 |
Intra-uterine pressure catheter | 0 (0.0) | 2 (4) | 0 (0.0) | 1 (2) | 0.3 |
Time from enrollment until delivery, min | 352 ± 320 (241) | 457 ± 305 (384)a,c | 279 ± 210 (227) | 376 ± 232 (345)a | 0.001 |
Duration of the first stage of labor, min | 337 ± 316 (230) | 436 ± 292 (379)a | 262 ± 197 (214) | 364 ± 230 (332)a | 0.001 |
Time from enrollment until the beginning of the active phase, min | 260 ± 313 (164) | 336 ± 272 (276)a | 176 ± 197 (109) | 279 ± 237 (233)a | 0.001 |
Duration of the active phase, min | 76 ± 49 (70) | 99 ± 99 (65) | 90 ± 55 (81) | 87 ± 61(75) | 0.6 |
Duration of the second stage, min | 15 ± 31 (8) | 21 ± 32 (9) | 16 ± 29 (10) | 13 ± 15 (7) | 0.5 |
Delivery mode | Â | Â | Â | Â | 0.4 |
Spontaneous vaginal | 49 (100) | 51(98) | 52 (95) | 46 (98) | ---- |
Vacuum | 0 (0) | 0 (0) | 2 (4) | 0 (0) | ---- |
Cesarean | 0 (0) | 1 (2) | 1 (2) | 1 (2) | 0.9 |
Vacuum or cesarean | 0 (0) | 1 (2) | 3 (6) | 1 (2) | 0.4 |
Early post partum hemorrhage | 0 (0.0) | 2 (4) | 3 (6) | 0 (0.0) | 0.2 |
Post-partum fever | 1 (2.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.5 |
Women satisfaction | 4.9 ± 0.4 (5)b | 4.8 ± 0.5 (5)b | 4.9 ± 0.5 (5) | 5.0 ± 0.0 (5) | 0.01 |
Birthweight, gr | 3416 ± 391 (3396) | 3435 ± 470 (3456) | 3401 ± 417 (3376) | 3296 ± 368 (3282) | 0.4 |
Apgar score at 5 min | 10.0 ± 0.1 | 10.0 ± 0.3 | 10.0 ± 0.2 | 10.0 ± 0.2 | 0.8 |